TOP NEWS: AstraZeneca Imfinzi Combination Trial Provides Mixed Results
LONDON (Alliance News) - AstraZeneca PLC said Tuesday its Imfinzi combination late stage clinical trial for metastatic non-small cell lung cancer had mixed results after one sub-study failed to of Read More